456 related articles for article (PubMed ID: 31354747)
1. CD4
Kato R; Sumitomo S; Tsuchida Y; Tsuchiya H; Nakachi S; Sakurai K; Hanata N; Nagafuchi Y; Kubo K; Tateishi S; Kanda H; Okamura T; Yamamoto K; Fujio K
Front Immunol; 2019; 10():1619. PubMed ID: 31354747
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
4. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
5. CD4(+)CD25(+)CD127(-) and CD4(+)CD25(+)Foxp3(+) Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients.
Żabińska M; Krajewska M; Kościelska-Kasprzak K; Jakuszko K; Bartoszek D; Myszka M; Klinger M
Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):399-407. PubMed ID: 27156107
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
[TBL] [Abstract][Full Text] [Related]
7. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
[TBL] [Abstract][Full Text] [Related]
9. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
10. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
11. Increased CD4
Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L
Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752
[TBL] [Abstract][Full Text] [Related]
12. The relation of CD4
Kamal M; Gabr H; Anwar S; Bastawy S; Salah L
Lupus; 2022 Apr; 31(4):463-471. PubMed ID: 35249399
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus.
Kleczynska W; Jakiela B; Plutecka H; Milewski M; Sanak M; Musial J
Folia Histochem Cytobiol; 2011; 49(4):646-53. PubMed ID: 22252759
[TBL] [Abstract][Full Text] [Related]
14. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
15. Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.
Pan X; Yuan X; Zheng Y; Wang W; Shan J; Lin F; Jiang G; Yang YH; Wang D; Xu D; Shen L
PLoS One; 2012; 7(4):e34662. PubMed ID: 22506043
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus.
Ma L; Zhao P; Jiang Z; Shan Y; Jiang Y
Clin Exp Immunol; 2013 Dec; 174(3):345-55. PubMed ID: 23968502
[TBL] [Abstract][Full Text] [Related]
17. Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome.
Álvarez-Rodríguez L; Martínez-Taboada V; Calvo-Alén J; Beares I; Villa I; López-Hoyos M
Front Immunol; 2019; 10():391. PubMed ID: 30894863
[No Abstract] [Full Text] [Related]
18. Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients.
Zhao C; Chu Y; Liang Z; Zhang B; Wang X; Jing X; Hao M; Wang Y; An J; Zhang X; Sun L; Chen J
BMC Immunol; 2019 Sep; 20(1):32. PubMed ID: 31484501
[TBL] [Abstract][Full Text] [Related]
19. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
20. RORγt expression in T
Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
